Diop Mame-Kany, Albadine Roula, Kougioumoutzakis André, Delvoye Nathalie, Hovington Hélène, Bergeron Alain, Fradet Yves, Saad Fred, Trudel Dominique
Centre de recherche du Centre hospitalier de l'Université de Montréal (axe Cancer) and Institut du cancer de Montréal, 900 Saint-Denis, Montréal, QC H2X 0A9, Canada.
Department of Pathology and Cellular Biology, Université de Montréal, 2900 Boulevard Édouard-Montpetit, Montreal, QC H3T 1J4, Canada.
Cancers (Basel). 2021 Dec 13;13(24):6243. doi: 10.3390/cancers13246243.
Intraductal carcinoma of the prostate (IDC-P) is an aggressive subtype of prostate cancer strongly associated with an increased risk of biochemical recurrence (BCR). However, approximately 40% of men with IDC-P remain BCR-free five years after radical prostatectomy. In this retrospective multicenter study, we aimed to identify histologic criteria associated with BCR for IDC-P lesions. A total of 108 first-line radical prostatectomy specimens were reviewed. In our test cohort ( = 39), presence of larger duct size (>573 µm in diameter), cells with irregular nuclear contours (CINC) (≥5 CINC in two distinct high-power fields), high mitotic score (>1.81 mitoses/mm), blood vessels, and comedonecrosis were associated with early BCR (<18 months) ( < 0.05). In our validation cohort ( = 69), the presence of CINC or blood vessels was independently associated with an increased risk of BCR (hazard ratio [HR] 2.32, 95% confidence interval [CI] 1.09-4.96, = 0.029). When combining the criteria, the presence of any CINC, blood vessels, high mitotic score, or comedonecrosis showed a stronger association with BCR (HR 2.74, 95% CI 1.21-6.19, = 0.015). Our results suggest that IDC-P can be classified as low versus high-risk of BCR. The defined morphologic criteria can be easily assessed and should be integrated for clinical application following validation in larger cohorts.
前列腺导管内癌(IDC-P)是前列腺癌的一种侵袭性亚型,与生化复发(BCR)风险增加密切相关。然而,约40%的IDC-P男性患者在根治性前列腺切除术后5年无BCR。在这项回顾性多中心研究中,我们旨在确定与IDC-P病变BCR相关的组织学标准。共回顾了108例一线根治性前列腺切除术标本。在我们的测试队列(n = 39)中,较大导管尺寸(直径>573 µm)、核轮廓不规则的细胞(CINC)(在两个不同的高倍视野中≥5个CINC)、高有丝分裂评分(>1.81个有丝分裂/mm)、血管和粉刺样坏死与早期BCR(<18个月)相关(P < 0.05)。在我们的验证队列(n = 69)中,CINC或血管的存在与BCR风险增加独立相关(风险比[HR] 2.32,95%置信区间[CI] 1.09 - 4.96,P = 0.029)。当合并这些标准时,任何CINC、血管、高有丝分裂评分或粉刺样坏死的存在与BCR的关联更强(HR 2.74,95% CI 1.21 - 6.19,P = 0.015)。我们的结果表明,IDC-P可分为BCR低风险和高风险。所定义的形态学标准易于评估,在更大队列中验证后应整合用于临床应用。